Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma

被引:6
|
作者
Motta, Juliana Maria [1 ]
Hassan, Hebatallah [2 ]
Ibrahim, Sherif Abdelaziz [2 ]
机构
[1] Univ Fed Rio De Janeiro, Hosp Univ Clementino Fraga Filho, Inst Bioquim Med Leopoldo De Meis, BR-21941 Rio De Janeiro, Brazil
[2] Cairo Univ, Fac Sci, Dept Zool, Giza 12613, Egypt
关键词
syndecans; breast cancer; tumor microenvironment; epithelial-mesenchymal transition; nuclear hormone receptors; microRNAs; exosomes; therapeutic perspectives; HEPARAN-SULFATE PROTEOGLYCANS; GROWTH-FACTOR RECEPTOR; CANCER CELL MOTILITY; ESTROGEN-RECEPTOR; FUNCTIONAL-PROPERTIES; ER-ALPHA; NUCLEAR RECEPTORS; INTEGRIN ACTIVITY; EXPRESSION; BETA;
D O I
10.3390/cancers15061794
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Syndecans (SDCs; SDC1 to 4) are integral cell surface proteoglycans that are expressed normally on various types of mammalian tissues. In cancer, SDCs' expression is dysregulated, impacting the onset and progression of cancer by modulating pivotal signaling pathways involved in biological and molecular functions. In this review, we highlight the key roles of SDCs in breast cancer pathogenesis, addressing the prognostic value and the critical molecular regulators of SDC expression, as well as different SDC-centered therapeutic perspectives. Syndecans (SDC1 to 4), a family of cell surface heparan sulfate proteoglycans, are frequently expressed in mammalian tissues. SDCs are aberrantly expressed either on tumor or stromal cells, influencing cancer initiation and progression through their pleiotropic role in different signaling pathways relevant to proliferation, cell-matrix adhesion, migration, invasion, metastasis, cancer stemness, and angiogenesis. In this review, we discuss the key roles of SDCs in the pathogenesis of breast cancer, the most common malignancy in females worldwide, focusing on the prognostic significance and molecular regulators of SDC expression and localization in either breast tumor tissue or its microenvironmental cells and the SDC-dependent epithelial-mesenchymal transition program. This review also highlights the molecular mechanisms underlying the roles of SDCs in regulating breast cancer cell behavior via modulation of nuclear hormone receptor signaling, microRNA expression, and exosome biogenesis and functions, as well as summarizing the potential of SDCs as promising candidate targets for therapeutic strategies against breast cancer.
引用
收藏
页数:24
相关论文
共 50 条
  • [31] Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment
    Zhu, Zhipeng
    Ye, Weipeng
    Wu, Xiaofang
    Lin, Sihao
    Xu, Jiuhua
    Li, Lulu
    Li, Jiayi
    Wang, Haibin
    Huang, Zhengjie
    BIOSCIENCE REPORTS, 2021, 41 (01)
  • [32] LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target
    Catharina Hagerling
    Mark Owyong
    Vaishnavi Sitarama
    Chih-Yang Wang
    Charlene Lin
    Renske J. E. van den Bijgaart
    Charlotte D. Koopman
    Audrey Brenot
    Ankitha Nanjaraj
    Fredrik Wärnberg
    Karin Jirström
    Ophir D. Klein
    Zena Werb
    Vicki Plaks
    BMC Cancer, 20
  • [33] LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target
    Hagerling, Catharina
    Owyong, Mark
    Sitarama, Vaishnavi
    Wang, Chih-Yang
    Lin, Charlene
    van den Bijgaart, Renske J. E.
    Koopman, Charlotte D.
    Brenot, Audrey
    Nanjaraj, Ankitha
    Warnberg, Fredrik
    Jirstrom, Karin
    Klein, Ophir D.
    Werb, Zena
    Plaks, Vicki
    BMC CANCER, 2020, 20 (01)
  • [34] An analysis of DKK1-CKAP4 signaling as a prognostic factor and potential therapeutic target of hepatocellular carcinoma
    Sada, Ryota
    Iguchi, Kosuke
    Matsumoto, Shinji
    Zen, Yoh
    Akita, Masayuki
    Gon, Hidetoshi
    Fukumoto, Takumi
    Kikuchi, Akira
    CANCER SCIENCE, 2025, 116 : 157 - 157
  • [35] Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA dataoase
    Zhou, Jingcheng
    Wang, Jiangyi
    Hong, Baoan
    Ma, Kaifang
    Xie, Haibiao
    Li, Lei
    Zhang, Kenan
    Zhou, Bowen
    Cai, Lin
    Gong, Kan
    AGING-US, 2019, 11 (06): : 1633 - 1647
  • [36] Ductal Carcinoma In Situ of the Breast: Influence of Age on Diagnostic, Therapeutic, and Prognostic Features. Retrospective Study of 812 Patients
    Tunon-de-Lara, Christine
    Andre, Gwenaelle
    MacGrogan, Gaetan
    Dilhuydy, Jean-Marie
    Bussieres, Jean-Emmanuel
    Debled, Marc
    Mauriac, Louis
    Brouste, Veronique
    de Mascarel, Isabelle
    Avril, Antoine
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (05) : 1372 - 1379
  • [37] Ductal Carcinoma In Situ of the Breast: Influence of Age on Diagnostic, Therapeutic, and Prognostic Features. Retrospective Study of 812 Patients
    Christine Tunon-de-Lara
    Gwenaëlle André
    Gaétan MacGrogan
    Jean-Marie Dilhuydy
    Jean-Emmanuel Bussières
    Marc Debled
    Louis Mauriac
    Véronique Brouste
    Isabelle de Mascarel
    Antoine Avril
    Annals of Surgical Oncology, 2011, 18 : 1372 - 1379
  • [38] Correlation of the suvmax of fdg-pet and adc values of diffusion-weighted mri with pathologic prognostic factors in breast carcinoma
    Kitajima, Kazuhiro
    Yamano, Toshiko
    Fukushima, Kazuhito
    Miyoshi, Yasuo
    Hirota, Seiichi
    Kawanaka, Yusuke
    Mouri, Miya
    Maruyama, Kaoru
    Doi, Hiroshi
    Hirota, Shozo
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [39] Prognostic values of KAI1 and survivin expression in an infiltrating ductal carcinoma of the breast (vol 37, pg 131, 2005)
    Son, BH
    Choi, JS
    Lee, JH
    PATHOLOGY, 2005, 37 (04) : 331 - 331
  • [40] Is metaplastic breast cancer more aggressive than "classic" triple-negative ductal carcinoma? Recent prognostic and therapeutic consideration
    Girardi, A.
    Magnoni, F.
    Veronesi, P.
    Corso, G.
    BREAST, 2021, 56 : S85 - S86